IBDEI0O7 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11303,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,11303,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,11304,0)
 ;;=N41.4^^47^530^71
 ;;^UTILITY(U,$J,358.3,11304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11304,1,3,0)
 ;;=3^Prostatitis,Granulomatous
 ;;^UTILITY(U,$J,358.3,11304,1,4,0)
 ;;=4^N41.4
 ;;^UTILITY(U,$J,358.3,11304,2)
 ;;=^52938
 ;;^UTILITY(U,$J,358.3,11305,0)
 ;;=N41.3^^47^530^72
 ;;^UTILITY(U,$J,358.3,11305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11305,1,3,0)
 ;;=3^Prostatocystitis
 ;;^UTILITY(U,$J,358.3,11305,1,4,0)
 ;;=4^N41.3
 ;;^UTILITY(U,$J,358.3,11305,2)
 ;;=^270418
 ;;^UTILITY(U,$J,358.3,11306,0)
 ;;=N70.93^^47^530^73
 ;;^UTILITY(U,$J,358.3,11306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11306,1,3,0)
 ;;=3^Salpingitis & Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,11306,1,4,0)
 ;;=4^N70.93
 ;;^UTILITY(U,$J,358.3,11306,2)
 ;;=^5015808
 ;;^UTILITY(U,$J,358.3,11307,0)
 ;;=R39.16^^47^530^77
 ;;^UTILITY(U,$J,358.3,11307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11307,1,3,0)
 ;;=3^Straining to Void
 ;;^UTILITY(U,$J,358.3,11307,1,4,0)
 ;;=4^R39.16
 ;;^UTILITY(U,$J,358.3,11307,2)
 ;;=^5019346
 ;;^UTILITY(U,$J,358.3,11308,0)
 ;;=N53.9^^47^530^74
 ;;^UTILITY(U,$J,358.3,11308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11308,1,3,0)
 ;;=3^Sexual Dysfunction,Male,Unspec
 ;;^UTILITY(U,$J,358.3,11308,1,4,0)
 ;;=4^N53.9
 ;;^UTILITY(U,$J,358.3,11308,2)
 ;;=^5015769
 ;;^UTILITY(U,$J,358.3,11309,0)
 ;;=R37.^^47^530^75
 ;;^UTILITY(U,$J,358.3,11309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11309,1,3,0)
 ;;=3^Sexual Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,11309,1,4,0)
 ;;=4^R37.
 ;;^UTILITY(U,$J,358.3,11309,2)
 ;;=^5019339
 ;;^UTILITY(U,$J,358.3,11310,0)
 ;;=N43.40^^47^530^76
 ;;^UTILITY(U,$J,358.3,11310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11310,1,3,0)
 ;;=3^Spermatocele of Epididymis,Unspec
 ;;^UTILITY(U,$J,358.3,11310,1,4,0)
 ;;=4^N43.40
 ;;^UTILITY(U,$J,358.3,11310,2)
 ;;=^5015701
 ;;^UTILITY(U,$J,358.3,11311,0)
 ;;=N44.8^^47^530^78
 ;;^UTILITY(U,$J,358.3,11311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11311,1,3,0)
 ;;=3^Testis Noninflammatory Disorder,Other
 ;;^UTILITY(U,$J,358.3,11311,1,4,0)
 ;;=4^N44.8
 ;;^UTILITY(U,$J,358.3,11311,2)
 ;;=^5015706
 ;;^UTILITY(U,$J,358.3,11312,0)
 ;;=N44.00^^47^530^79
 ;;^UTILITY(U,$J,358.3,11312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11312,1,3,0)
 ;;=3^Torsion of Testis,Unspec
 ;;^UTILITY(U,$J,358.3,11312,1,4,0)
 ;;=4^N44.00
 ;;^UTILITY(U,$J,358.3,11312,2)
 ;;=^334199
 ;;^UTILITY(U,$J,358.3,11313,0)
 ;;=R36.9^^47^530^82
 ;;^UTILITY(U,$J,358.3,11313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11313,1,3,0)
 ;;=3^Urethral Discharge,Unspec
 ;;^UTILITY(U,$J,358.3,11313,1,4,0)
 ;;=4^R36.9
 ;;^UTILITY(U,$J,358.3,11313,2)
 ;;=^5019338
 ;;^UTILITY(U,$J,358.3,11314,0)
 ;;=N36.9^^47^530^83
 ;;^UTILITY(U,$J,358.3,11314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11314,1,3,0)
 ;;=3^Urethral Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,11314,1,4,0)
 ;;=4^N36.9
 ;;^UTILITY(U,$J,358.3,11314,2)
 ;;=^5015677
 ;;^UTILITY(U,$J,358.3,11315,0)
 ;;=N35.9^^47^530^84
 ;;^UTILITY(U,$J,358.3,11315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11315,1,3,0)
 ;;=3^Urethral Stricture,Unspec
 ;;^UTILITY(U,$J,358.3,11315,1,4,0)
 ;;=4^N35.9
 ;;^UTILITY(U,$J,358.3,11315,2)
 ;;=^5015671
 ;;^UTILITY(U,$J,358.3,11316,0)
 ;;=N34.1^^47^530^86
 ;;^UTILITY(U,$J,358.3,11316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11316,1,3,0)
 ;;=3^Urethritis,Nonspecific
 ;;^UTILITY(U,$J,358.3,11316,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,11316,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,11317,0)
 ;;=N34.3^^47^530^85
